FDA's new drug application process won't attract sunscreen ingredient proposals even though the other option, the OTC monograph system, currently is untenable, say drug and personal care product industry stakeholders in a Government Accountability Office report.
The GAO report submitted to the leadership of the House and Senate committees with oversight of FDA (see box below)...




